Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenVeron Ramsuran, Hemant Kulkarni, Weijing He, et al.
ACS Infectious Diseases|June 8, 2017
Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico InsightsEleanor R Gray, Jennifer C Brookes, Christophe Caillat, et al.
Plos One|April 13, 2011
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesAnna Hultberg, Nigel J Temperton, Valérie Rosseels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
T cell responses to whole SARS coronavirus in humansChris Ka-fai Li, Hao Wu, Huiping Yan, et al.
Science (New York, N.Y.)|January 25, 2014
Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineageElizabeth P Murchison, David C Wedge, Ludmil B Alexandrov, et al.
Structure (London, England : 1993)|April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding siteTongqing Zhou, Lei Chen, Jason Gorman, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
Mbio|April 23, 2015
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillasHannah J Barbian, Julie M Decker, Frederic Bibollet-Ruche, et al.
Pageof 16